StockDriftsStockDriftsTop 2 Avalon Ventures Management, Llc Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| KLTR | KALTURA INC | 90.83% | 8.96M | $12.9M | +0.00%(+0) | $2.05(-19.02%) | 2025-09-30 | |
| JANX | JANUX THERAPEUTICS INC | 9.17% | 53.3K | $1.3M | +23.09%(+10.00K) | $25.83(-44.83%) | 2025-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (3 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — | -32.90% |
| Top 20 Holdings Unweighted | — | — | — | — | -18.94% |
Avalon Ventures Management, Llc reports $14.21M in US-listed equity holdings across 2 positions in its most recent 13F filing. Its largest disclosed positions are KLTR (90.8%) and JANX (9.2%). The top 20 holdings account for 100% of reported assets. Its disclosed equity book has returned -32.90% cumulatively over 3 quarters. Figures reflect the Q3 2025 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Avalon Ventures Management, Llc, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Avalon Ventures Management, Llc’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 2026666). View Avalon Ventures Management, Llc’s 13F filings on SEC